Article
T cell population expansion in response to allogeneic cancer vaccine alone (DPV-001) or with granulocyte-macrophage colony-stimulating factor (GM-CSF) or imiquimod (I) for definitively-treated stage III NSCLC patients (pts).
Journal of Clinical Oncology
(2017)
Disciplines
Publication Date
May 30, 2017
Citation Information
Bernard A. Fox, Brian C. Boulmay, Rui Li, Kyle T Happel, et al.. "T cell population expansion in response to allogeneic cancer vaccine alone (DPV-001) or with granulocyte-macrophage colony-stimulating factor (GM-CSF) or imiquimod (I) for definitively-treated stage III NSCLC patients (pts)." Journal of Clinical Oncology (2017) Available at: http://works.bepress.com/walter-urba/94/